<SEC-DOCUMENT>0001564590-23-007055.txt : 20230508
<SEC-HEADER>0001564590-23-007055.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508081529
ACCESSION NUMBER:		0001564590-23-007055
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230508
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MAIA Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001878313
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41455
		FILM NUMBER:		23895938

	BUSINESS ADDRESS:	
		STREET 1:		444 WEST LAKE STREET, SUITE 1700
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-416-8592

	MAIL ADDRESS:	
		STREET 1:		444 WEST LAKE STREET, SUITE 1700
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>maia-8k_20230508.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-05-05T21:54:45.4166606+00:00 -->
<!-- Version            : 5.0.1.788 -->
<!-- Package ID         : f6a5f963a2df44bcbd0602b4b2d963a6 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:maia="http://maiabiotech.com/20230508" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
maia-8k_20230508.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001878313_20230508_20230508">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001878313_20230508_20230508">0001878313</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="maia-20230508.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001878313_20230508_20230508">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001878313</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2023-05-08</xbrli:startDate>
					<xbrli:endDate>2023-05-08</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION <span style="font-weight:normal;">&#160;</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001878313_20230508_20230508">8-K</ix:nonNumeric>&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Current Report <span style="font-weight:normal;">&#160;</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001878313_20230508_20230508" format="ixt:datemonthdayyearen">May 8, 2023</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001878313_20230508_20230508">MAIA Biotechnology, Inc.</ix:nonNumeric></span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:32%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:2%; border-bottom:solid 1pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:32%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityFileNumber" contextRef="C_0001878313_20230508_20230508">001-41455</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:2%; border-bottom:solid 1pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:32%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001878313_20230508_20230508">83-1495913</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction<br />of incorporation) </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number) </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer<br />Identification No.) </p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:49%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine1" contextRef="C_0001878313_20230508_20230508">444 West Lake Street, Suite 1700</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0001878313_20230508_20230508">Chicago</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0001878313_20230508_20230508">IL</ix:nonNumeric> </p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:2%; border-bottom:solid 1pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:49%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0001878313_20230508_20230508">60606</ix:nonNumeric></p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices) </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code) </p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: <span style="font-weight:bold;"><ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0001878313_20230508_20230508">(312)</ix:nonNumeric></span> <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0001878313_20230508_20230508">416-8592</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:EntityInformationFormerLegalOrRegisteredName" contextRef="C_0001878313_20230508_20230508">N/A</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:WrittenCommunications" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td valign="top" style="width:5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:95%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:SolicitingMaterial" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td valign="top" style="width:5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:95%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementTenderOffer" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td valign="top" style="width:5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:95%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:95%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.5%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:32%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:2%; border-bottom:solid 1pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:32%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:2%; border-bottom:solid 1pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:32%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which <br />registered</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CCEEFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:Security12bTitle" contextRef="C_0001878313_20230508_20230508">Common Stock</ix:nonNumeric></p></td>
<td valign="bottom" style="background-color:#CCEEFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CCEEFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:TradingSymbol" contextRef="C_0001878313_20230508_20230508">MAIA</ix:nonNumeric></p></td>
<td valign="bottom" style="background-color:#CCEEFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CCEEFF;padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000023" name="dei:SecurityExchangeName" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:exchnameen">NYSE American</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000006" name="dei:EntityExTransitionPeriod" contextRef="C_0001878313_20230508_20230508" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 2.02. Results of Operations and Financial Condition.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 8, 2023, MAIA Biotechnology, Inc. (the &#8220;Company&#8221;) issued a press release announcing its results of operations for the quarter ended March 31, 2023, attached hereto as Exhibit 99.1. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 7.01. Regulation FD Disclosure.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Press Release </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As disclosed in Item 2.02 above, on May 8, 2023, the Company issued a press release announcing its results of operations for the quarter ended March 31, 2023, attached hereto as Exhibit 99.1. </p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information set forth in Items 2.02 and 7.01 of this Current Report on Form 8-K and in the attached Exhibit 99.1 is deemed to be &#8220;furnished&#8221; and shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section. The information set forth in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Forward-Looking Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company cautions that all statements, other than statements of historical facts, contained in this Current Report on Form 8-K, or furnished herewith, are forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry&#8217;s actual results, levels or activity, performance or achievements to be materially different from those anticipated by such statements. The use of words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;future,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; and other similar expressions are intended to identify forward looking statements. However, the absence of these words does not mean that statements are not forward-looking. For example, all statements we make regarding (i) the initiation, timing, cost, progress and results of our preclinical and clinical studies and our research and development programs, (ii) our ability to advance product candidates into, and successfully complete, clinical studies, (iii) the timing or likelihood of regulatory filings and approvals, (iv) our ability to develop, manufacture and commercialize our product candidates and to improve the manufacturing process, (v) the rate and degree of market acceptance of our product candidates, (vi) the size and growth potential of the markets for our product candidates and our ability to serve those markets, and (vii) our expectations regarding our ability to obtain and maintain intellectual property protection for our product candidates, are forward looking. All forward-looking statements are based on current estimates, assumptions and expectations by our management that, although we believe to be reasonable, are inherently uncertain. Any forward-looking statement expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and are subject to risks and uncertainties and other factors beyond our control that may cause actual results to differ materially from those expressed in any forward-looking statement. Any forward-looking statement speaks only as of the date on which it was made. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01. Financial Statements and Exhibits.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.69%;"></td>
<td style="width:92.31%;"></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibits:</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No.</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:90%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="maia-ex991_6.htm"><span style="text-decoration:underline;">Press release dated May 8, 2023.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:15.38%;text-indent:-15.38%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:3.85%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:45%;">
<tr>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dated: May 8, 2023</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MAIA BIOTECHNOLOGY, INC.</p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:11.12%; border-bottom:solid 1pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.88%; border-bottom:solid 1pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">/s/ Vlad Vitoc</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vlad Vitoc</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>maia-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
maia-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gukjsu04u1q0000001.jpg" title="" alt="" style="width:184px;height:70px;"></p>
<p style="text-align:center;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;margin-left:3.85%;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Helvetica;letter-spacing:-0.1pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk79997709"></a>MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:14pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:10pt;font-family:Helvetica;">Reported positive topline data from the completed Part A safety lead-in of the THIO-101 Phase 2 go-to-market trial in advanced Non-Small Cell Lung Cancer (NSCLC) and commenced recruitment in Part B randomized efficacy/dose selection </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:10pt;font-family:Helvetica;">Outlined preliminary safety data from Part A survival safety data from THIO-101 with first two enrolled patients alive after approximately 10 and 9 months post treatment initiation, respectively</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:10pt;font-family:Helvetica;">Reported strong efficacy of THIO in liver in vivo cancer models; study showed THIO with complete and durable responses in Hepatocellular Carcinoma (HCC), the dominant histology of primary liver cancer (90%), </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:10pt;font-family:Helvetica;">Raised approximately $5.75 million in gross proceeds from public offering of 2,555,500 shares of common stock at a public offering price of $2.25 per share</font></p></td></tr></table></div>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">CHICAGO &#8211; May 8, 2023 -- </font><font style="font-weight:bold;Background-color:#FFFFFF;">MAIA Biotechnology, Inc.</font><font style="Background-color:#FFFFFF;">, (NYSE American: MAIA) (&#8220;MAIA&#8221;, the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.</font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">&#8220;We are thrilled with the advancement of the THIO-101 trial, inclusive of reporting the positive topline data and preliminary survival data from the completed Part A safety lead-in of our ongoing phase 2 trial,&#8221; said Vlad Vitoc, M.D., MAIA&#8217;s Chairman and Chief Executive Officer. &#8220;The clinical activity seen with THIO thus far, in addition to its favorable safety and efficacy profiles, puts us one step closer to our goal of treating NSCLC and liver cancer. Additionally, we are proud to have strengthened our balance sheet by completing the follow-on offering. As we progress through the year, we look forward to our plan to share the safety data from Part B randomized efficacy/dose selection and receive IND clearance in the U.S.&#8221;</font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Corporate Highlights</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:9pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#212529;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk118670091"></a><a name="_Hlk118712887"></a>Reported&#160;positive topline data from the completed Part A safety lead-in of the THIO-101 Phase 2 go-to-market trial in advanced Non-Small Cell Lung Cancer (NSCLC) and commenced recruitment in Part B randomized efficacy/dose selection:<font style="Background-color:#FFFFFF;font-size:12pt;font-weight:normal;"> </font><font style="font-weight:normal;">Topline data from Part A demonstrated that MAIA&#8217;s telomere-targeting agent, THIO, administered in sequential combination with Regeneron&#8217;s anti-PD-1 therapy, Libtayo&#174;&#160;(cemiplimab), were generally well-tolerated.</font></p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#212529;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Reported preliminary survival data in Part A of THIO-101 Phase 2 trial for Non-Small Cell Lung Cancer: <font style="font-weight:normal;">As of April 2023, the first two patients enrolled in Part A continued to be alive, approximately 10 and 9 months, respectively, from treatment initiation. Both patients have advanced Stage IV metastatic disease and are heavily pretreated, receiving third and fourth line of therapy, respectively, after previously failing treatment with an immune checkpoint inhibitor.</font></p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#212529;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Reported strong efficacy of THIO in liver in vivo cancer models: <font style="font-weight:normal;">Study showed THIO with complete and durable responses in Hepatocellular Carcinoma (HCC), which is the dominant histology in primary liver cancer (90%). When combined with immunotherapy checkpoint inhibitor (CPI), the duration of response was further potentiated. Administration of THIO alone and in combination with CPI generated anti-cancer immune memory. Upon rechallenge with two times more cancer cells and no additional treatment, tumor growth was completely prevented.</font></p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#212529;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Closed common stock public offering: <font style="font-weight:normal;">Raised gross proceeds of approximately $5.75 million, before deducting underwriting discounts and offering expenses, in a public offering of 2,555,500 shares of common stock at a public offering price of $2.25 per share. </font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">First Quarter 2023 Financial Results</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Cash Position: <font style="font-weight:normal;">The </font><font style="color:#000000;font-weight:normal;">Company had cash totaling </font><font style="font-weight:normal;">approximately $7.6 million </font><font style="color:#000000;font-weight:normal;">as of March 31, 2023, compared </font><font style="font-weight:normal;">to $10.9 million </font><font style="color:#000000;font-weight:normal;">in cash as of March 31, 2022.&nbsp;&nbsp;The&nbsp;&nbsp;amount as of March 31, 2023 does not include the net proceeds from the public offering of shares of common stock received subsequent to quarter end. </font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Research and Development (R&amp;D) Expenses:<font style="font-weight:normal;"> R&amp;D expenses were </font><font style="font-weight:normal;color:#000000;">approximately $2.2 million </font><font style="font-weight:normal;">for the quarter ended March 31, 2023, compared to </font><font style="font-weight:normal;color:#000000;">approximately $2.1 million </font><font style="font-weight:normal;">for quarter ended March 31, 2022. The increase was primarily related to an increase in payroll and bonus expenses of approximately $0.46 million related to the increased headcount of additional research and development employees offset by a decrease in Clinical and Scientific research fees of approximately $0.23 million due less THIO-101 trial start-up fees, </font><font style="font-weight:normal;color:#000000;">and a decrease in consulting and other fees of approximately $0.12 million. R&amp;D expenses included approximately $0.3 million and $0.3 million of non-cash stock compensation expense in the first quarter of 2023 and 2022, respectively.</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;color:#000000;"> </font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">General and Administrative (G&amp;A) Expenses: <font style="font-weight:normal;">G&amp;A expenses were approximately $2.0 million for the quarter ended March 31, 2023, compared to approximately $1.4 million for the quarter ended March 31, 2022. The increase for the quarter was primarily due to approximate increases in payroll and bonus expenses of $0.3 million, an increase of approximately $0.6 million of other expenses related to the costs of operating as a public company, offset by a decrease in stock-based compensation of approximately $0.2 million and professional fees of approximately $0.1 million. G&amp;A expenses included approximately $0.3 million and $0.4 million of non-cash stock compensation expense in the quarters ended March 31, 2023, and 2022, respectively. </font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Other Income (Expense): <font style="font-weight:normal;">Other income was approximately $0.07 million for the quarter ended March 31, 2023, and other expense for the quarter ended March 31, 2022 was approximately $0.03 million. The increase was primarily related to increases in the Australia research and development incentives of approximately $0.02 million and a gain on the change in the fair value of the warrant liability of approximately $0.02 million, offset by increases to interest expense of approximately $0.005 million. </font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Net Income (Loss): <font style="font-weight:normal;">Net loss was approximately $4.1 million for the quarter ended March 31, 2023, as compared to net loss of approximately $3.9 million for the quarter ended March 31, 2022. </font></p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">About THIO</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THIO (6-thio-dG or 6-thio-2&#8217;-deoxyguanosine) is an investigational telomere-targeting agent currently in clinical development to evaluate its activity in non-small cell lung cancer (NSCLC). Telomeres, along with the enzyme telomerase, play a fundamental role in the survival of cancer cells and their resistance to current therapies. THIO is being developed as a second or later line of treatment for NSCLC for patients that have progressed beyond the standard-of-care regimen of existing checkpoint inhibitors.</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">About MAIA Biotechnology, Inc.</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FEFEFE;">MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit&#160;</font><font style="Background-color:#FEFEFE;text-decoration:underline;">www.maiabiotech.com</font><font style="Background-color:#FEFEFE;">.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Forward Looking Statements</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MAIA cautions that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry&#8217;s actual results, levels or activity, performance or achievements to be materially different from those anticipated by such statements. The use of words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;future,&#8221; &#8220;potential,&#8221; or &#8220;continue,&#8221; and other similar expressions are intended to identify forward looking statements. However, the absence of these words does not mean that statements are not forward-looking. For example, all statements we make regarding (i) the initiation, timing, cost, progress and results of our preclinical and clinical studies and our research and development programs, (ii) our ability to advance product candidates into, and successfully complete, clinical studies, (iii) the timing or likelihood of regulatory filings and approvals, (iv) our ability to develop, manufacture and commercialize our product candidates and to improve the manufacturing process, (v) the rate and degree of market acceptance of our product candidates, (vi) the size and growth potential of the markets for our product candidates and our ability to serve those markets, and (vii) our expectations regarding our ability to obtain and maintain intellectual property protection for our product candidates, are forward looking. All forward-looking statements are based on current estimates, assumptions and expectations by our management that, although we believe to be reasonable, are inherently uncertain. Any forward-looking statement expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and are subject to risks and uncertainties and other factors beyond our control that may cause actual results to differ materially from those expressed in any forward-looking statement. Any forward-looking statement speaks only as of the date on which it was made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. In this release, unless the context requires otherwise, &#8220;MAIA,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; refers to MAIA Biotechnology, Inc. and its subsidiaries.</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Contact:</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MAIA Biotechnology </p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Joseph McGuire</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">jmcguire@maiabiotech.com</font></p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">904-228-2603</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ICR Westwicke </p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stephanie Carrington</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stephanie.Carrington@westwicke.com</font></p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">646-277-1282</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gukjsu04u1q0000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gukjsu04u1q0000001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "A :@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHK$^(7Q(\ ?";PC=^/?B;XQTW0=%L5!O-4U:[2"&+)"J"S$#<S$*JCE
MF( !) II.3LA.2BKLVZ,@=37YP_M2?\ !PA\-O"C3^&_V3OA[)XINUW+_P )
M+XDCDM=/4C85:.W!6>=2"X.\VY4J"-X/'QKXG_;2_P""GO[=?B&XT#PEXN\<
M:LBAS+X?^'6GS6UO;PRL!MF6S4,\0. &N&? _BY->K1R?%5(\T[17G_E_G8\
M;$9[@Z4N2G>;\MOO_P KG[A?$+XU_!KX20QW'Q6^+?AGPS',VV%_$&O6]D'/
MH#,ZY/TKRGQC_P %0OV ? MS]EUK]J;PO,V[&='FDU%?^^K1)!^M?EQ\._\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%?#__  5>_P""JEC^R9IL
MWP+^!U_:WGQ*O[4-=WFU98O#<+KE9)%.5:Y92&CB8$!2LC@J423;#X>IB:JI
MP6O]:LY\5BJ.$HNI4=DOQ\EYG<?\%!O^"J'P9_8DTVY\&:9Y?B?XB20*;/PS
M:SXCLMX#++>R#_4KL.\1C,D@*8"J_FK^5\D_[>W_  5R^-<OE+J'B:>WG#F%
M&-MHOAR&0G:.3Y<"[4(&2TTHB/,K@FNR_P"">O\ P3%^+'_!0#Q1<?&;XO\
MB#5]+\#S:A)+J7B:X8R7^OW)D/G+;O+NWG?NWW#!E#Y&'8,%_9[X/?!CX5_
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MSCNM/O[.0/%<0R*&216'52I!!]ZX,;@:F#J6>J>S[GJ9?F%+,*=XZ26Z[?\
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M  4 #Z"<O[)P:A'^)/=]E_7XW/EZ<7GF.=27\&&B7=_\'=^5EU*/QQ\;:/\
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MM%?!3PVP^(VBVH;4+.QCRWB.SC7'EE0,O<QHH\MA\SJOE$-^Z\OYE_X(E?\
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M_P#(^>SKW\5AJ;V<OUC_ )G[MCI10**\0^A/%?\ @HU_R8C\6/\ L1[_ /\
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M *7V5<1_P79_Y2":M_V+>F?^B:[?_@W;_P"3NO&'_9.)_P#TOLJ^KJ?\B/\
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M9YE".&2I/6:^Y?Y]/O/%RC*:E3%N5=:0>W=_Y=?N[GAO_!9__E&I\2?^X/\
M^GFQK\&:_>;_ (+/_P#*-3XD_P#<'_\ 3S8U^#-/(?\ <Y?XG^2%Q+_OT?\
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M[6-KB.-HXYF0;T1BI90>H!**2.Y5?05)117&=Q\N_P#!9_\ Y1J?$G_N#_\
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MVAB9+X>6*?K?3\$S\9/^"[/_ "D$U;_L6],_]$UV_P#P;M_\G=>,/^R<3_\
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MO%TO7IAIS?;-#O"I_>>8I^9"!YP&UBRQSIA3Y;5-^V7^V1\2="^+O@3]D_\
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MY-(\3R:]J$.L:QHUNOEB.;[?&<@;06*X7]U;L&!!1E]H_P""J_\ R/?[./\
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M5%'8 "I/#GAS0/".A6?ACPKH=GIFFZ?;I!8Z?I]LD,%M$HPL<:( J* ,!0
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MS)X5M99E]_,D1GS[YS1]:R>'PT6_5_\ !8_J>?5-)UTO1?\  1^,VJ?M4_\
M!4C]NZ\D\,Z'XT^(/BJ&.,0WFE^"M->UM$CE?@7*V$<<93/&^?( '+8!KU[]
MG'_@@'^TW\1;F'5_C_XGTOP#I?)ELHY%U'4GP5( 2)O(0,"WS&4LI S&:_8Z
MSL[33[6.QL;6.&&% D4,,8544=  . *DJ:F<5(QY:$%!>7])?@.GD%&4N?$U
M)5'YNWZM_B>%_LE_\$Z/V6/V-(%O?A5X$^U:\T/EW'BS79!=:C(OS9"OM"P
MAMI6%8PP"[@Q&:]T QP***\FI4J59<TW=^9[=*E3HPY*:279!1114&@4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>maia-20230508.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-05-05T21:54:45.4166606+00:00 -->
<!-- Version            : 5.0.1.788 -->
<!-- Package ID         : f6a5f963a2df44bcbd0602b4b2d963a6 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:maia="http://maiabiotech.com/20230508" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://maiabiotech.com/20230508" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://maiabiotech.com/20230508/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="maia-20230508_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="maia-20230508_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>maia-20230508_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-05-05T21:54:45.4166606+00:00 -->
<!-- Version            : 5.0.1.788 -->
<!-- Package ID         : f6a5f963a2df44bcbd0602b4b2d963a6 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Information, Former Legal or Registered Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information Former Legal Or Registered Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>maia-20230508_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-05-05T21:54:45.4166606+00:00 -->
<!-- Version            : 5.0.1.788 -->
<!-- Package ID         : f6a5f963a2df44bcbd0602b4b2d963a6 -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://maiabiotech.com/20230508/role/TemplateLink" xlink:href="maia-20230508.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="maia-20230508.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:type="locator" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139961226156768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  08,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MAIA Biotechnology, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001878313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-1495913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">444 West Lake Street, Suite 1700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chicago<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(312)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">416-8592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MAIA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>maia-8k_20230508_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="maia-20230508.xsd" xlink:type="simple"/>
    <context id="C_0001878313_20230508_20230508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001878313</identifier>
        </entity>
        <period>
            <startDate>2023-05-08</startDate>
            <endDate>2023-05-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001878313_20230508_20230508" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001878313_20230508_20230508" id="F_000004">0001878313</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001878313_20230508_20230508" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001878313_20230508_20230508" id="F_000002">2023-05-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001878313_20230508_20230508" id="F_000003">MAIA Biotechnology, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001878313_20230508_20230508" id="F_000008">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001878313_20230508_20230508" id="F_000007">001-41455</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001878313_20230508_20230508" id="F_000009">83-1495913</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001878313_20230508_20230508" id="F_000010">444 West Lake Street, Suite 1700</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0001878313_20230508_20230508" id="F_000011">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001878313_20230508_20230508" id="F_000012">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001878313_20230508_20230508" id="F_000013">60606</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001878313_20230508_20230508" id="F_000014">(312)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001878313_20230508_20230508" id="F_000015">416-8592</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="C_0001878313_20230508_20230508" id="F_000016">N/A</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="C_0001878313_20230508_20230508" id="F_000017">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001878313_20230508_20230508" id="F_000018">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001878313_20230508_20230508" id="F_000019">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001878313_20230508_20230508" id="F_000020">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001878313_20230508_20230508" id="F_000021">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001878313_20230508_20230508" id="F_000022">MAIA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001878313_20230508_20230508" id="F_000023">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001878313_20230508_20230508" id="F_000005">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001878313_20230508_20230508" id="F_000006">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .U!J%8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #M0:A6G6O#B.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R';H&";-I:.G#@8K;.QF;+4UBQ-C:R1]^SE9FS*V!]C1TN]/
MGT"U"<KT$9]C'S"2PW0W^K9+RH0U.Q$%!9#,";U.94YTN7GHH]>4G_$(09L/
M?420G-^#1])6DX8)6(2%R)K:&F4B:NKC!6_-@@^?L9UAU@"VZ+&C!*(4P)II
M8CB/;0TWP 0CC#Y]%] NQ+GZ)W;N +LDQ^26U# ,Y5#-N;R#@+>GW<N\;N&Z
M1+HSF'\EI^@<<,VNDU^KS>-^RQK)957P5<$?]D(JL5)2O$^N/_QNPKZW[N#^
ML?%5L*GAUUTT7U!+ P04    " #M0:A6F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M .U!J%8'.Z#$DP0  -(1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9A];^)&$,:_RLJ5JCLIB5]X"4D!B9#<%5V20R%MU%;]8[$'>Q7;2W?7(7S[
MSAIBTZL9HTC!;_OXY]G99\8>;J1ZU0F 8>]9FNN1DQBSOG9='2:0<7TAUY#C
MF954&3>XJV)7KQ7PJ!R4I6[@>7TWXR)WQL/RV%R-A[(PJ<AAKI@NLHRK[0VD
M<C-R?.?CP).($V,/N./AFL>P //;>JYPSZU4(I%!KH7,F8+5R)GXUS=!WPXH
MK_A=P$8?;#/[*$LI7^W.+!HYGB6"%$)C)3C^O,$4TM0J(<<_>U&GNJ<=>+C]
MH?ZE?'A\F"77,)7IBXA,,G(&#HM@Q8O4/,G-K[!_H)[5"V6JR_]LL[NV%S@L
M++21V7XP$F0BW_WR]WT@#@9T.D<&!/L!0<F]NU%)><L-'P^5W#!EKT8UNU$^
M:CD:X41N9V5A%)X5.,Z,;V588) -XWG$[G(CS);-\MUL8]2&KL&;V$O=<"]X
MLQ,,C@@^\"WS!F<L\(+.?T>[B%;Q!15?4,IUCLA-Y1LH]M=DJ8W"&?R["6BG
MT&U6L&E]K=<\A)&#>:M!O8$S_ODGO^_]0O!U*KX.I5['[WF[AB8X>OC@_!L!
MT:T@NJ3*! FBDN)+RN,F"GK\BJ<:"(Y>Q=$[+1AS4$+:?(H89F5C7&@EFT5E
M&K7E4;]"ZY."^]1^@EC83$+&1YXU@M$Z#Y/9A-T(:2!,<IG*>'N&ZR6\(! O
M*\3+4Q"G&$#%4U2-X)U]@VT3)*WD>9X_N!QT?"IR@PIK< K6708J%GG,ON)X
MD["IS-8\;X2C]8PJJ%R[JK"N3L)Z9\\XG5J4'K_+NR8F6JQM ?A>;:?>*5A?
M1 KLL<B6H!HME!;!Z3OO^MU>CT(Z<'C_%"3,4JG64I6^?L86!A<FDPHGLL"$
MP[R34>-Z:%&_O:,@:YOW29?^@'SF[VP6X0H0*Q&6I%04:<E!Y]SO7O6NR%7@
MUT;OTU:])YQ$$581??:QP>[Q.O8];XX=+=GM=MD+:,/N^2O@C"BLXC@SA<"9
M\2\]C^*N:X-/F_N/W%.[A_/^+#?-Y9V6FR8X,;&DT.IRX=,N_R-:E9-S)=]$
M'C;'E-:<W5-H=;GP3ZH7%=I<:H.F_*=8'U\HM&+?PS^*K:X3/FWOY0Q.L <_
MCD(+?.KXP6<*I:X-/FWF]S+$J,P3F9-V1XMT_?[YH'<54$1U6?!/J@L'/>P9
ML_T[=I'W$",LIM>N"P %T=$NH.4NC^Z$:F[K<A'03O^BA#&0VVJ:%?G>\G1C
MDTL+M56PH"X7 6WH"YF*$,LIEOH'7(Y*\+21AU9IY3EX :!M?*[@/,3P /K!
MKM/&9A=G\_MJU9QM+7JM9'5%"&C[_A_93.L"R5H!:=E6P-KZ ]JKGX7!-D2N
MF!]\6GYF"P@+S+?&GJU%R>8GUN*%D>$KA59;?T#;-#9MD4VQQ39;RN8$:WE#
MP$:<(JF=/J!]^2,JV$J&"<]C..H)+4*/?RSN)@]W3TU4[L$;NOW:\<!M,ZU9
M"BO4\BXN\6'5[@/";L?(=?G2OI3&R*S<3(!C6MD+\/Q*XBO(?L=^!Z@^XXS_
M!5!+ P04    " #M0:A6GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX;6S=
M5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I=67=
MA['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[I#)6
M,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4!H-?
MRA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBAC05C
M$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.B^4M
M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4?-@#
ME_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&?>S\
M;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQY+/!
MI!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,
MD_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJOE]?
M\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[021>
M\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%^@2O
M&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R
M^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%N
MV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2='@/
M/GL?)=-[*CG_5U/\!%!+ P04    " #M0:A6EXJ[',     3 @  "P   %]R
M96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:
MI7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$
MVV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_
M,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH
M^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( .U!J%8<.&7J/P$  #P"
M   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+5$2XE#Z0JA:5
MBON2=8C%/B*O RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(A:Z9FWF6I;(&
M;])-;"#(I(KD#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU$QE*QA@$[( =
MPCG]SKM6G3#A'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&;4N*SA5Z,@QV
M0(SE'WC;B?PT^]0C;/8?1H04>I8+8864N-_H^8UH/($L#UW+\0D= ZT,PS/%
MML%PZ&C$179EH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:FZ15,!X*/:XH
M$ZQZ#"PAJ748J&2W<RJGUW9PS2+W*D.:HPQH;0?AHUH+%0:P;W(@"2[)E1M2
M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " #M0:A6)!Z;HJT
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M2P$"% ,4    " #M0:A6!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .U!J%:=:\.([@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M .U!J%:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ [4&H5@<[H,23!   TA$  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M .U!J%:?H!OPL0(  .(,   -              "  =8,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ [4&H5I>*NQS     $P(   L              ( !
ML@\  %]R96QS+RYR96QS4$L! A0#%     @ [4&H5APX9>H_ 0  / (   \
M             ( !FQ   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .U!
MJ%8D'INBK0   /@!   :              "  0<2  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .U!J%9ED'F2&0$  ,\#   3
M          "  >P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  #84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="maia-8k_20230508.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="maia-8k_20230508.htm">maia-8k_20230508.htm</File>
    <File>maia-20230508.xsd</File>
    <File>maia-20230508_lab.xml</File>
    <File>maia-20230508_pre.xml</File>
    <File>maia-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "maia-8k_20230508.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "maia-8k_20230508.htm"
     ]
    },
    "labelLink": {
     "local": [
      "maia-20230508_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "maia-20230508_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "maia-20230508.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "maia",
   "nsuri": "http://maiabiotech.com/20230508",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "maia-8k_20230508.htm",
      "contextRef": "C_0001878313_20230508_20230508",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "maia-8k_20230508.htm",
      "contextRef": "C_0001878313_20230508_20230508",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information Former Legal Or Registered Name",
        "terseLabel": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://maiabiotech.com/20230508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-23-007055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-23-007055-xbrl.zip
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MA1L,U;_'*)P,!Y/!T!N$H]$H&/T>!),@J GXN[ !U'X3,/0"+_3>7U[6&+]
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MU_@^J; VZ[ZK@*2N=<^117=3DUVT2'@NLUPZBCPS\\LYVH,5B K!H%&P;7@
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MRK[*IB*"-PL@$:;/CWU\>?ZVT89?_6XH4R4Z8F!P8@V<W87*1&8)F/&T#,=
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M/.Q\\[+'UZH_/=KU_Z3IHUW_3Z?^/U!+ 0(4 Q0    ( .Y!J%8F*&LWL 0
M /X5   1              "  0    !M86EA+3(P,C,P-3 X+GAS9%!+ 0(4
M Q0    ( .Y!J%;%*R[7?@<  '9/   5              "  =\$  !M86EA
M+3(P,C,P-3 X7VQA8BYX;6Q02P$"% ,4    " #N0:A6H@>;^"X%   /+P
M%0              @ &0#   ;6%I82TR,#(S,#4P.%]P<F4N>&UL4$L! A0#
M%     @ [D&H5J_$[,PQ%0  9;8  !0              ( !\1$  &UA:6$M
M.&M?,C R,S U,#@N:'1M4$L! A0#%     @ [D&H5C7-2D31$P  JW4  !
M             ( !5"<  &UA:6$M97@Y.3%?-BYH=&U02P4&      4 !0!%
) 0  4SL

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
